Pediatric soft tissue sarcomas

Surgical Oncology Clinics of North America

Volumn 12, Issue 2, 2003, Pages 419-447

  Herzog, Cynthia E ^a   Stewart, John M M ^a   Blakely, Martin L ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHILDHOOD CANCER; CLINICAL FEATURE; EMBRYONAL RHABDOMYOSARCOMA; HUMAN; REVIEW; RHABDOMYOSARCOMA; SARCOMA; SOFT TISSUE SARCOMA;

EID: 0038076221     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(03)00007-3     Document Type: Review

References (101)

1. Gurney JG, Young JL, Roffers SD, et al. Soft tissue sarcomas. In: Reis LAG, Smith MA, Gurney JG, et al, editors. Cancer incidence and survival among children and adolescents: United States SEER program, 1975-1995. Bethesda MD: National Cancer Institute SEER Program; 1999. p. 111-123. Publication NIH #99-4649.
2. Matsui I, Tanimura M, Kobayashi N, et al. Neurofibromatosis type 1 and childhood cancer. Cancer 1993;72:2746-54.
3. Qualman S, Coffin CM, Newton WA. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol 1998;1:550-61.
4. Anderson J, Gordon T, McManus A, et al. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Br J Cancer 2001;85:831-5.
5. Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13:610-30.
6. Crist WM, Anderson JR, Meza JL, et al. Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001;19:3091-102.
7. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-1. A final report. Cancer 1988;61:209-20.
8. Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-III. Cancer 1993;71:1904-22.
9. Breitfeld PP, Lyden E, Raney RB, et al. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Hematol Oncol 2001;23:225-33.
10. Sandler E, Lyden E, Ruymann F, et al. Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. Med Pediatr Oncol 2001;37:442-8.
11. Weigel BJ, Breitfeld PP, Hawkins D, et al. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma. J Pediatr Hematol Oncol 2001;23:272-6.
12. Wolden SL, Anderson JR, Crist WM, et al. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcomas: a report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol 1999;17:3468-75.
13. Nag S, Ruymann FB, Martinez-Monge R, et al. Use of brachytherapy to preserve function in children with soft-tissue sarcomas. Oncology 1999;13:361-70.
14. Andrassy RJ, Wiener ES, Raney RB, et al. Progress in the surgical management of vaginal rhabdomyosarcoma: a 25-year review from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Surg 1999;34:731-4.
15. Arndt CA, Donaldson SS, Anderson JR, et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer 2001;91:2454-68.
16. Gharimi F. Genitourinary RMS. In: Maurer HM, Ruymann FB, Pochedly C, editors. RMS and related tumors in children and adolescents. Boca Raton, FL: CRC Press; 1991. p. 347-62.
17. Hays DM, Raney RB, Wharam M, et al. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy: a report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee. J Pediatr Hematol Oncol 1995;17:46-52.
18. Blakely ML, Andrassy RJ, Raney RB, et al. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus. J Pediatr Surg 2003 (in press).
19. Hays DM, Lawrence W Jr, Wharam M, et al. Primary reexcision for patients with "microscopic residual" tumor following initial excision of sarcomas of trunk and extremity sites. J Pediatr Surg 1989;24:5-10.
20. Cofer BR, Wiener ES. Rhabdomyosarcoma. In: Andrassy RJ, editor. Pediatric surgical oncology. Philadelphia: WB Saunders; 1998. p. 221-37.
21. Neville HL, Andrassy RJ, Lobe TE, et al. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the International Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg 2000;35:317-21.
22. Neville HL, Andrassy RJ, Lally KP, et al. Lymphatic mapping with sentinel node biopsy in pediatric patients. J Pediatr Surg 2000;35:961-4.
23. Wiener ES, Anderson JR, Ojimba JI, et al. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Sem Pediatr Surg 2001;10:146-52.
24. Ferrari A, Bisogno G, Casanova M, et al. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group. J Clin Oncol 2002;20:449-55.
25. Wiener ES, Lawrence W, Hays D, et al. Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. Pediatr Surg Int 1994;29:171-7.
26. Dillon P, Maurer H, Jenkins J, et al. A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group. J Pediatr Surg 1992;27:241-5.
27. Hayes-Jordan AA, Spunt SL, Poquette CA, et al. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable? J Pediatr Surg 2000;35:948-53; discussion, 953-4.
28. Jenkin D, Sonley M. Soft-tissue sarcomas in the young: medical treatment advances in perspective. Cancer 1980;46:621-9.
29. McCoy DM, Levine EA, Ferrer K, et al. Pediatric soft tissue sarcomas of nonmyogenic origin. J Surg Oncol 1993;53:149-53.
30. Pratt CB, Pappo AS, Gieser P, et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J Clin Oncol 1999;17:1219-26.
31. Pappo AS, Rao BN, Jenkins JJ, et al. Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: the St. Jude Children's Research Hospital experience. Med Pediatr Oncol 1999;33:76-82.
32. Spunt SL, Poquette CA, Hurt YS, et al. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St. Jude Children's Research Hospital. J Clin Oncol 1999;17:3697-705.
33. Ferrari A, Casanova M, Massimino M, et al. Synovial sarcoma: report of a series of 25 consecutive children from a single institution. Med Pediatr Oncol 1999;32:32-7.
34. Ladenstein R, Treuner J, Koscielniak E, et al. Synovial sarcoma in childhood and adolescents. Report of the German CWS-81 study. Cancer 1993;71:3647-55.
35. Okcu MF, Despa S, Choroszy M, et al. Synovial sarcoma in children and adolescents: thirty three years of experience with multimodal therapy. Med Pediatr Oncol 2001;37:90-6.
36. Pappo AS, Fontanesi J, Luo X, et al. Synovial sarcoma in children and adolescents: the St Jude Children's Research Hospital experience. J Clin Oncol 1994;12:2360-6.
37. Schmidt D, Thum P, Harms D, et al. Synovial sarcoma in children and adolescents. A report from the Kiel Pediatric Tumor Registry. Cancer 1991;67:1667-72.
38. Sandberg AA, Bridge JA. Update on the cytogenetics and molecular genetics of bone and soft tissue tumors: synovial sarcoma. Cancer Genet Cytogenet 2002;133:1-23.
39. Rosen G, Forscher C, Lowenbraun S, et al. Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer 1994;73:2506-11.
40. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 2002;62:135-40.
41. Chung EB, Enzinger FM. Infantile fibrosarcoma. Cancer 1976;38:729-39.
42. Soule EH, Pritchard DJ. Fibrosarcoma in infants and children. A review of 110 cases. Cancer 1977;40:1711-21.
43. Kurkchubasche AG, Halvorson EG, Forman EN, et al. The role of preoperative chemotherapy in the treatment of infantile fibrosarcoma. J Pediatr Surg 2000;35:880-3.
44. Shetty AK, Yu LC, Gardner RV, et al. Role of chemotherapy in the treatment of infantile fibrosarcoma. Med Pediatr Oncol 1999;33:425-7.
45. Madden NP, Spicer RD, Allibone EB, et al. Spontaneous regression of neonatal fibrosarcoma. Br J Cancer 1992;18:S72-5.
46. Enzinger FM. Hemangiopericytoma. In: Weiss SW, editor. Soft tissue tumors. 2nd edition. St. Louis, MO: Mosby; 1988. p. 596-613.
47. Kauffman SL, Stout AP. Hemangiopericytoma in children. Cancer 1960;13:695-710.
48. Bailey PV, Weber TR, Tracy TF, et al. Congenital hemangiopericytoma: an unusual vascular neoplasm of infancy. Surgery 1993;114:936-41.
49. Atkinson JB, Mahour GH, Isaacs H Jr, et al. Hemangiopericytoma in infants and children: a report of six patients. Am J Surg 1984;148:372-4.
50. Chen KT, Kassel SH, Medrano VA. Congenital hemangiopericytoma. J Surg Oncol 1986;31:127-9.
51. Casanova M, Ferrari A, Spreafico F, et al. Malignant peripheral nerve sheath tumors in children: a single-institution twenty-year experience. J Pediatr Hematol Oncol 1999;21:509-13.
52. Ducatman BS, Scheithauer BW, Piepgras DG, et al. Malignant peripheral nerve sheath tumors in childhood. J Neurooncol 1984;2:241-8.
53. Meis JM, Enzinger FM, Martz KL, et al. Malignant peripheral nerve sheath tumors (malignant schwannoma) in children. Am J Surg Pathol 1992;16:694-707.
54. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 1986;314:1010-5.
55. Ducatman BS, Scheithauer BW, Piepgras DG, et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986;57:2006-21.
56. Wong WW, Hirose T, Scheithauer BW, et al. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 1998;42:351-60.
57. Castleberry RP, Kelly DR, Wilson ER, et al. Childhood liposarcoma: report of a case and review of the literature. Cancer 1984;54:579-84.
58. Ferrari A, Casanova M, Spreafico F, et al. Childhood liposarcoma: a single-institutional twenty-year experience. Pediatr Hematol Oncol 1999;16:415-21.
59. LaQuaglia MP, Spiro SA, Ghavimi F, et al. Liposarcoma in patients younger than or equal to 22 years of age. Cancer 1993;72:3114-9.
60. Shmookler BM, Enzinger FM. Liposarcoma occurring in children. An analysis of 17 cases and review of the literature. Cancer 1983;52:567-74.
61. Chang HR, Hajdu SI, Collin C, et al. The prognostic value of histologic subtypes in primary extremity liposarcoma. Cancer 1989;64:1514-20.
62. Gerald WL, Ladanyi M, de Alava E, et al. Clinical, pathological, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol 1998;16:3028-36.
63. Ordonez NG. Desmoplastic small round cell tumor I: a histopathologic study of 39 cases with emphasis on unusual histopathological patterns. Am J Surg Pathol 1998;22:1303-13.
64. Ordonez NG. Desmoplastic small round cell tumor II: an ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am J Surg Pathol 1998;22:1314-27.
65. Athale UH, Shurtleff SA, Jenkins JJ, et al. Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor. J Pediatr Hematol Oncol 2001;23:99-104.
66. Bisogno G, Roganovich J, Sotti G, et al. Desmoplastic small round cell tumour in children and adolescents. Med Pediatr Oncol 2000;34:338-42.
67. Farhat F, Culine S, Lhomme C, et al. Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients. Cancer 1996;77:1363-6.
68. Gonzalez-Crussi F, Crawford SE, Sun CC. Intraabdominal desmoplastic small-cell tumors with divergent differentiation: observations on three cases of childhood. Am J Surg Pathol 1990;14:633-42.
69. Kushner BH, LaQuaglia MP, Wollner N, et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol 1996;14:1526-31.
70. Rosoff PM, Bayliff S. Successful clinical response to irinotecan in desmoplastic round blue cell tumor. Med Pediatr Oncol 1999;33:500-3.
71. Chung EB, Enzinger FM. Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol 1983;7:405-13.
72. Sara AS, Evans HL, Benjamin RS. Malignant melanoma of soft parts (clear cell sarcoma). A study of 17 cases, with emphasis on prognostic factors. Cancer 1990;65:367-74.
73. Zucman J, Delattre O, Desmaze C, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 1993;4:341-5.
74. Lieberman PH, Brennan MF, Kimmel M, et al. Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer 1989;63:1-13.
75. Casanova M, Ferrari A, Bisogno G, et al. Alveolar soft part sarcoma in children and adolescents: a report from the Soft-Tissue Sarcoma Italian Cooperative Group. Ann Oncol 2000;11:1445-9.
76. Pappo AS, Parham DM, Cain A, et al. Alveolar soft part sarcoma in children and adolescents: clinical features and outcome of 11 patients. Med Pediatr Oncol 1996;26:81-4.
77. Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001;20:48-57.
78. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001;159:179-92.
79. Belchis D, Dillon P. NRSTS. In: Andrassy RJ, editor. Pediatric surgical oncology. Philadelphia: WB Saunders; 1998. p. 315-36.
80. Hussain HK, Kingston JE, Domizio P, et al. Imaging-guided core biopsy for the diagnosis of malignant tumors in pediatric patients. Am J Roentgenol 2001;176:43-7.
81. Holcomb GW III, Tomita SS, Haase GM, et al. Minimally invasive surgery in children with cancer. Cancer 1995;76:121-8.
82. Hardaway BW, Hoffer FA, Rao BW. Needle localization of small pediatric tumors for surgical biopsy. Pediatr Radiol 2000;30:318-22.
83. Blakely ML, Spurbeck WW, Pappo AS, et al. The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Pediatr Surg 1999;34:672-5.
84. Trovik CS, Bauer HC, Alvegard TA, et al. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 2000;36:710-6.
85. Stojadinovic A, Lering DHY, Hoos A. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg 2002;235:424-34.
86. Midis GP, Pollock RE, Chen NP, et al. Locally recurrent soft tissue sarcoma of the extremities. Surgery 1998;123:666-71.
87. Cecchetto G, Guglielmi M, Inserra A, et al. Primary re-excision: the Italian experience in patients with localized soft-tissue sarcomas. Pediatr Surg Int 2001;17:532-4.
88. Cecchetto G, Carli M, Sotti G, et al. Importance of local treatment in pediatric soft tissue sarcomas with microscopic residual after primary surgery: results of the Italian Cooperative Study RMS-88. Med Pediatr Oncol 2000;34:97-101.
89. Ben Arush MW, Nahum MP, Meller I, et al. The role of chemotherapy in childhood soft tissue sarcomas other than RMS: experience of the Northern Israel Oncology Center. Pediatr Hematol Oncol 1999;16:397-406.
90. Temple WJ, Temple CL, Arthur K, et al. Prospective cohort study of neoadjuvant treatment in conservative surgery of soft tissue sarcomas. Ann Oncol 1997;4:586-90.
91. Gortzak E, Azzarelli A, Buesa J, et al. A randomized phase II study on neo-adjuvant chemotherapy for "high-risk" adult soft-tissue sarcoma. Eur J Cancer 2001;37:1096-103.
92. Pollack A, Zagars GK, Goswitz MS, et al. Preoperative versus postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation. Int J Radiat Oncol Biol Phys 1998;42:563-72.
93. Kunisada T, Ngan SY, Powell G, et al. Wound complications following preoperative radiotherapy for soft tissue sarcoma. Eur J Surg Oncol 2002;28:75-9.
94. Alektiar KM, Velasco J, Zelefsky MJ, et al. Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys 2000;48:1051-8.
95. Nag S, Tippin D, Rhymann FB. Intraoperative high-dose-rate brachytherapy for the treatment of pediatric tumors: the Ohio State University experience. Int J Radiat Oncol Biol Phys 2001;51:729-35.
96. Nag S, Shasha D, Janjan N, et al. The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2001;49:1033-43.
97. Saenz NC, LaQuaglia MP. Metastasis from solid tumors. In: Andrassy RJ, editor. Pediatric surgical oncology. Philadelphia: WB Saunders; 1998. p. 405-17.
98. Knezevich SR, McFadden DE, Tao W, et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nature Genetics 1998;18:184-7.
99. Ladanyi M. The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol 1995;4:162-73.
100. Panagopoulos I, Hoglund M, Mertens F, et al. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 1996;12:489-94.
101. Limon J, Rao U, Dal Cin P, et al. Translocation (13;22) in a hemangiopericytoma. Cancer Genetics & Cytogenetics 1986;21:309-18.